Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO-B) Minority Interest (2009 - 2012)

Bio-Rad Laboratories (BIO-B) reported Minority Interest of $535000.0 for Q4 2012, up 20.22% year-over-year from $445000.0 in Q1 2012, and down 10.83% on a QoQ basis from $600000.0 in Q3 2012.

Bio-Rad Laboratories (BIO-B) has 4 years of Minority Interest data on file, last reported at $535000.0 in Q4 2012.

  • Quarterly Minority Interest rose 20.22% year-over-year to $535000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $535000.0 (up 20.22% YoY) and the FY2012 annual result came in at $535000.0, up 20.22% from the prior year.
  • Minority Interest slipped to $535000.0 in Q4 2012 per BIO-B's latest filing, from $600000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $19.5 million in Q4 2009 and bottomed at $81000.0 in Q2 2011.
  • The 4-year median for Minority Interest is $602000.0 (2012), against an average of $4.1 million.
  • The widest annual swing landed in 2011, when Minority Interest slumped 99.54%; it then soared 645.68% in 2012.
  • Tracing BIO-B's Minority Interest over 4 years: stood at $19.5 million in 2009, then sank by 80.38% to $3.8 million in 2010, then sank by 88.36% to $445000.0 in 2011, then rose by 20.22% to $535000.0 in 2012.
  • Per Business Quant, the three latest BIO-B Minority Interest figures stand at $535000.0 (Q4 2012), $600000.0 (Q3 2012), and $604000.0 (Q2 2012).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Bio-Rad Laboratories - - 309.40 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 535,000.00
Sep 30, 2012 600,000.00
Jun 30, 2012 604,000.00
Mar 31, 2012 397,000.00
Dec 31, 2011 445,000.00
Sep 30, 2011 497,000.00
Jun 30, 2011 81,000.00
Mar 31, 2011 1.20 Mn
Dec 31, 2010 3.82 Mn
Sep 30, 2010 4.30 Mn
Jun 30, 2010 17.60 Mn
Dec 31, 2009 19.49 Mn